Please assess the completion status of the following clinical trial:

Trial Title: Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion:~1. You must be between the ages of 18 and 75. If you have reached your 76th birthday, you will not be able to participate~2. You must have been diagnosed with schizophrenia~3. You must be able to visit the doctor's office as scheduled for the next 7 months~Exclusion:~1. You have a serious medical illness, such as heart, liver, or kidney disease (Note: If you are uncertain about a particular condition, discuss it with your doctor.)~2. You are either pregnant or breastfeeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).